Clinical outcomes after bare metal stenting in diabetic patients with lesions carrying a low risk of restenosis
Catheterization and Cardiovascular Interventions, 05/09/2012
Woudstra P et al. – No difference was observed in target lesion revascularization (TLR) or composite clinical endpoint at one–year between non–DM and NIRDM after bare–metal stent (BMS) placement in coronary artery lesions carrying a low risk of restenosis. The presence of IRDM was associated with higher TLR rates when treated with BMS. These results imply that BMS placement may be considered in patients with NIRDM but further work is required to define treatment strategies and, more importantly, improve the outcomes in diabetics.